EicOsis
About:
EicOsis Human Health is developing a first-in-class therapy of a once daily
Website: http://www.eicosis.com/
Top Investors: Good Ventures, Open Philanthropy
Description:
EicOsis is developing inhibitors to a the soluble epoxide hydrolase, a key regulatory enzyme involved in the metabolism of fatty acids, to treat unmet medical needs in human and animals.sEH inhibitors treat pain by stabilizing natural analgesic and anti-inflammatory mediators.
Total Funding Amount:
$10M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Davis, California, United States
Founded Date:
2011-01-01
Contact Email:
info(AT)eicosis.com
Founders:
Bruce Hammock
Number of Employees:
1-10
Last Funding Date:
2019-03-18
IPO Status:
Private
Industries:
© 2025 bioDAO.ai